highperformr logo

Abion's Overview

Total employees224
HeadquartersIncheon
Founded1994

Abion Inc. is a South Korean clinical-stage biopharmaceutical company committed to the discovery and development of innovative medicines targeting intractable diseases, with a primary focus on oncology and rare conditions. Leveraging advanced drug development platforms and a dedicated research team, Abion strives to translate scientific breakthroughs into effective therapies that address significant unmet medical needs globally. The company's pipeline includes promising candidates like ABN401, a c-MET inhibitor.

Where is Abion's Headquarters?

HQ Function

Serves as the central hub for all corporate functions, including research and development of novel therapeutics, clinical trial management, strategic planning, and administrative operations.

Notable Features:

Strategically situated within the Songdo Bio-Valley, a leading South Korean biotechnology cluster, offering access to state-of-the-art research infrastructure, a skilled talent pool, and a collaborative R&D ecosystem.

Work Culture:

Characterized by a strong emphasis on scientific innovation, rigorous research methodologies, and collaboration. The culture likely fosters intellectual curiosity and a patient-centric approach to drug development, typical of clinical-stage biopharmaceutical firms.

HQ Significance:

Its location in Songdo Bio-Valley is critical for Abion's mission, enabling synergies with other biotech entities, academic institutions, and access to specialized facilities essential for advancing its drug pipeline.

Values Reflected in HQ: The headquarters' location and focus reflect Abion's core values of innovation, scientific excellence, and commitment to addressing unmet medical needs through advanced biopharmaceutical research.

Location:

While headquartered in South Korea, Abion Inc. maintains a global outlook, particularly in its clinical development programs which often involve international sites, including the United States for key trials like ABN401. The company actively seeks to bring its innovative therapies for cancer and rare diseases to patients worldwide by engaging with global regulatory bodies and pursuing international research collaborations and potential commercialization partnerships.

Street Address:

C-702, Songdo Bio-Valley, 15 Songdomirae-ro

City:

Incheon

State/Province:

Yeonsu-gu

Country:

Republic of Korea

Abion's Global Presence

Buying Intent Signals for Abion

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Abion

As of April 2025, Abion' leadership includes:

Dongho Shin - Chief Executive Officer (CEO) & President
Kyung-Nyun Kim - Chief Technology Officer (CTO) & Head of R&D Center
Young Sang Kim - Head of New Drug Development Division
Jae Wan Lee - Head of Clinical Development Division
Hee Jung Park - Head of Management Support Division

Investors of Abion

Abion has been backed by several prominent investors over the years, including:

Korea Investment Partners
Dayli Partners
Tellus Investment
Quad Investment Management
Company K Partners
Publicly traded on KOSDAQ (Symbol: 203400)

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits0

No major executive hires or exits at Abion Inc. have been widely reported in readily available English-language public sources over the last 12 months, suggesting leadership stability. Key executive information is typically disclosed via Korean financial regulatory filings (DART).

Technology (Tech Stack) used by Abion

Discover the tools Abion uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Abion Email Formats and Examples

Abion Inc. likely utilizes a standardized email format for its employees, common in professional Korean companies. While the exact predominant pattern is not publicly confirmed, typical structures often involve combinations of the employee's Romanized name and the company domain, abionbio.com.

[firstinitial][lastname]@abionbio.com

Format

dshin@abionbio.com (example for Dongho Shin)

Example

65%

Success rate

News and media

KED Global / The BellJanuary 24, 2024

Abion Inc. Completes Patient Recruitment for US Phase 2 Trial of ABN401

Abion Inc. has successfully completed patient enrollment for the U.S. Phase 2 clinical trial of ABN401, its lead c-MET inhibitor candidate. This milestone paves the way for accelerating its entry into the global market for treating cancers driven by MET alterations....more

The Korea HeraldJanuary 10, 2024

Abion Inc.'s c-MET inhibitor ABN401 shows full remission effect in phase 2 trial

Abion Inc. announced promising results from its phase 2 clinical trial of ABN401, a c-MET targeted therapy, demonstrating a complete remission in a patient with non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutations. The data highlights ABN401's potential as an effective treatment....more

Korea Biomedical ReviewNovember 2, 2023

Abion wins orphan drug designation for ABN401 from MFDS

Abion's ABN401, a treatment for non-small cell lung cancer (NSCLC), has received orphan drug designation (ODD) from the Ministry of Food and Drug Safety (MFDS) in Korea. This designation is for drugs treating rare diseases and offers benefits like expedited review....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Abion, are just a search away.